Feng Shu, Wei Bin, Liu Qianqian, Wang Tingting, Li Dongdong, Rao Chenli, Tao Chuanmin, Wang Lanlan
Department of Laboratory Medicine/Clinical Research Center of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaUniversity of South Carolina School of Medicine Greenville.
Department of Laboratory Medicine/Clinical Research Center of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaUniversity of South Carolina School of Medicine Greenville
Clin Vaccine Immunol. 2016 Jul 5;23(7):652-4. doi: 10.1128/CVI.00078-16. Print 2016 Jul.
The hepatitis C virus (HCV) antibody assay remains the first-line screening test to identify HCV infection. The newly arrived HISCL Anti-HCV assay had a satisfactory seroconversion sensitivity. Its sensitivity and specificity were 98.97 and 100% for clinical samples. In general, the HISCL Anti-HCV assay may be a novel choice for clinical HCV screening.
丙型肝炎病毒(HCV)抗体检测仍然是识别HCV感染的一线筛查试验。新推出的希森美康抗-HCV检测具有令人满意的血清转化敏感性。对于临床样本,其敏感性和特异性分别为98.97%和100%。总体而言,希森美康抗-HCV检测可能是临床HCV筛查的一种新选择。